Literature DB >> 3236757

[Significance of arterial blood pressure for the development of microalbuminuria and retinopathy in type I diabetes mellitus].

B Watschinger1, C Schnack, S Bruck, N Stelzer, C Gisinger, G Schernthaner.   

Abstract

The role of hypertension for the combined occurrence of incipient diabetic nephropathy and diabetic retinopathy (RP) was evaluated in 155 insulin-dependent diabetic patients (74 male/81 female); mean age 32.4 +/- 12.2 STD years; means diabetes duration 12.8 +/- 10 STD years). Albumin excretion rate (AER) was measured in 24 hours urine samples by RIA, retinal status was determined by both, fundoscopy and fluorescein angiography. Analysis of the data revealed a statistically significant correlation between the duration of disease and elevated AER (p less than 0.012), and the occurrence of retinopathy (p less than 0.0001). Although there was a close correlation between retinopathy and elevated AER (p less than 0.0001), it is remarkable that 31% of the patients with normal AER (less than 15 micrograms/min) showed signs of non proliferative RP. On the other hand 30% of patients without retinal changes showed an elevated AER (less than 15 micrograms/min). In the group of microalbuminuric patients (greater than 15 micrograms/min) systolic (p less than 0.004) and diastolic (p less than 0.04) blood pressures were significantly higher than in normoalbuminuric patients (less than 15 micrograms/min). Patients with proliferative retinopathy showed significantly higher systolic and diastolic (p less than 0.015) blood pressures compared to patients without retinal changes, though albumin excretion rates were not different in both groups of patients. In conclusion, our results show that diabetic nephropathy and diabetic retinopathy do not develop simultaneously in a representative number of insulin-dependent diabetic patients, but hypertension may be a major risk factor for the development of both microangiopathic complications.

Entities:  

Mesh:

Year:  1988        PMID: 3236757     DOI: 10.1007/bf01711920

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  13 in total

1.  Albuminuria and diabetic retinopathy.

Authors:  M Marre; D Bruel; P Passa
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

2.  Microalbuminuria and diabetic retinopathy.

Authors:  A H Barnett; K Dallinger; P Jennings; J Fletcher; O Odugbesan
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

3.  Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion.

Authors:  H H Parving; B Oxenbøll; P A Svendsen; J S Christiansen; A R Andersen
Journal:  Acta Endocrinol (Copenh)       Date:  1982-08

4.  Incipient nephropathy in type 1 (insulin-dependent) diabetes.

Authors:  E R Mathiesen; B Oxenbøll; K Johansen; P A Svendsen; T Deckert
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

5.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

6.  Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure.

Authors:  A Teuscher; H Schnell; P W Wilson
Journal:  Diabetes Care       Date:  1988-03       Impact factor: 19.112

7.  Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications.

Authors:  T Deckert; J E Poulsen; M Larsen
Journal:  Diabetologia       Date:  1978-06       Impact factor: 10.122

8.  Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.

Authors:  H H Parving; A R Andersen; U M Smidt; P A Svendsen
Journal:  Lancet       Date:  1983-05-28       Impact factor: 79.321

9.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.